Paid Clinical Trials Mobile
Discover 195 paid clinical trials in Mobile. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06393374
Conditions
Triple-Negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Sacituzumab tirumotecan
Capecitabine
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT04616326
Conditions
Chronic Migraine
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
Galcanezumab
Placebo
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor:
AstraZeneca
Location:
Code:
NCT06283966
Conditions
COPD (Chronic Obstructive Pulmonary Disease)
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
BGF MDI 320/14.4/9.6 μg
GFF MDI 14.4/9.6 μg
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
Sponsor:
AstraZeneca
Location:
Code:
NCT06268873
Conditions
Chronic Kidney Disease and Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Baxdrostat/dapagliflozin
Dapagliflozin in combination with placebo
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
Sponsor:
Ferring Pharmaceuticals
Location:
Code:
NCT04113382
Conditions
Bowel Preparation
Eligibility Criteria
Sex: All
Age: 2 - 8
Healthy Volunteers: Not accepted
Interventions
CLENPIQ
MIRALAX
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT04396574
Conditions
Migraine
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Lasmiditan
Study of Kidney Tumors in Younger Patients
Sponsor:
Children's Oncology Group
Location:
Code:
NCT00898365
Conditions
Adult Cystic Nephroma
Anaplastic Kidney Wilms Tumor
Angiolipoma
Cellular Congenital Mesoblastic Nephroma
Classic Congenital Mesoblastic Nephroma
Eligibility Criteria
Sex: All
Age: 0 - 29
Healthy Volunteers: Not accepted
Interventions
Cytology Specimen Collection Procedure
Laboratory Biomarker Analysis
National Cancer Institute "Cancer Moonshot Biobank"
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04314401
Conditions
Acute Myeloid Leukemia
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Clinical Stage III Cutaneous Melanoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Eligibility Criteria
Sex: All
Age: 13+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Medical Chart Review
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
Sponsor:
Shield Therapeutics
Location:
Code:
NCT05126901
Conditions
Anemia
Iron-deficiency
Eligibility Criteria
Sex: All
Age: 1 - 17
Healthy Volunteers: Not accepted
Interventions
Ferric Maltol
Ferrous sulfate
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
Sponsor:
Avalyn Pharma Inc.
Location:
Code:
NCT06329401
Conditions
Progressive Pulmonary Fibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AP01
Placebo